To build a model that used routine clinical information to screen for anxiety and depression, Patten's group studied 828 MS ...

Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...

This week's Guest Voice features Aranzazu Calzado, who says she was terrified to learn she had MS. Today, she's proud of her ...

MS patients in rural areas are 17% less likely to receive DMTs than those in urban areas, a study of Alberta, Canada, ...

Selma Blair discusses her health journey, updating fans on her Multiple Sclerosis, sharing her diagnosis story, and revealing ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

A University of Alberta study shows that rural Albertans living with multiple sclerosis are not as likely as urban patients ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral ...

Additionally, the Cadense sneakers are designed with an adjustable Velcro strap, which is great for a custom fit, as well as ...

American neurologist Stephen Hauser and Italian epidemiologist Alberto Ascherio were awarded the prestigious Breakthrough ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed.